316 related articles for article (PubMed ID: 11059780)
21. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
[TBL] [Abstract][Full Text] [Related]
22. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
23. RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.
Faried A; Faried LS; Kimura H; Nakajima M; Sohda M; Miyazaki T; Kato H; Usman N; Kuwano H
Eur J Cancer; 2006 Jul; 42(10):1455-65. PubMed ID: 16750623
[TBL] [Abstract][Full Text] [Related]
24. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
25. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
26. Distinct molecular signature of inflammatory breast cancer by cDNA microarray analysis.
Van Laere S; Van der Auwera I; Van den Eynden GG; Fox SB; Bianchi F; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
Breast Cancer Res Treat; 2005 Oct; 93(3):237-46. PubMed ID: 16172796
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic potential of erbB-2 in human mammary epithelial cells.
Pierce JH; Arnstein P; DiMarco E; Artrip J; Kraus MH; Lonardo F; Di Fiore PP; Aaronson SA
Oncogene; 1991 Jul; 6(7):1189-94. PubMed ID: 1713661
[TBL] [Abstract][Full Text] [Related]
28. Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines.
Wang B; Soule HD; Miller FR
Anticancer Res; 1997; 17(6D):4387-94. PubMed ID: 9494538
[TBL] [Abstract][Full Text] [Related]
29. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
[TBL] [Abstract][Full Text] [Related]
30. ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers.
Luo RZ; Fang X; Marquez R; Liu SY; Mills GB; Liao WS; Yu Y; Bast RC
Oncogene; 2003 May; 22(19):2897-909. PubMed ID: 12771940
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
32. Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC.
Kitzing TM; Wang Y; Pertz O; Copeland JW; Grosse R
Oncogene; 2010 Apr; 29(16):2441-8. PubMed ID: 20101212
[TBL] [Abstract][Full Text] [Related]
33. RhoC is essential for TGF-beta1-induced invasive capacity of rat ascites hepatoma cells.
Mukai M; Endo H; Iwasaki T; Tatsuta M; Togawa A; Nakamura H; Inoue M
Biochem Biophys Res Commun; 2006 Jul; 346(1):74-82. PubMed ID: 16750170
[TBL] [Abstract][Full Text] [Related]
34. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin.
Berquin IM; Dziubinski ML; Nolan GP; Ethier SP
Oncogene; 2001 Jul; 20(30):4019-28. PubMed ID: 11494130
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
36. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells.
Gallegos A; Gasdaska JR; Taylor CW; Paine-Murrieta GD; Goodman D; Gasdaska PY; Berggren M; Briehl MM; Powis G
Cancer Res; 1996 Dec; 56(24):5765-70. PubMed ID: 8971189
[TBL] [Abstract][Full Text] [Related]
37. RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis.
Hakem A; Sanchez-Sweatman O; You-Ten A; Duncan G; Wakeham A; Khokha R; Mak TW
Genes Dev; 2005 Sep; 19(17):1974-9. PubMed ID: 16107613
[TBL] [Abstract][Full Text] [Related]
38. Caveolin-1 mediates inflammatory breast cancer cell invasion via the Akt1 pathway and RhoC GTPase.
Joglekar M; Elbezanti WO; Weitzman MD; Lehman HL; van Golen KL
J Cell Biochem; 2015 Jun; 116(6):923-33. PubMed ID: 25559359
[TBL] [Abstract][Full Text] [Related]
39. Critical role of c-Jun overexpression in liver metastasis of human breast cancer xenograft model.
Zhang Y; Pu X; Shi M; Chen L; Song Y; Qian L; Yuan G; Zhang H; Yu M; Hu M; Shen B; Guo N
BMC Cancer; 2007 Aug; 7():145. PubMed ID: 17672916
[TBL] [Abstract][Full Text] [Related]
40. Bag1 proteins regulate growth and survival of ZR-75-1 human breast cancer cells.
Kudoh M; Knee DA; Takayama S; Reed JC
Cancer Res; 2002 Mar; 62(6):1904-9. PubMed ID: 11912172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
